NAT10 dysregulation has been observed in diseases such as Hutchinson‐Gilford progeria syndrome and some cancer types, including colorectal, hepatocellular carcinoma, pancreatic cancer and melanoma.13, 14, 15, 16, 17, 18. This evidence concerns the gene NAT10 and hepatocellular carcinoma.